Alpha Cognition (ACOG) vs Innate Pharma S.A. (IPHA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Alpha Cognition (ACOG) has outperformed Innate Pharma S.A. (IPHA) over the past year, gaining 17.1% versus a loss of 26.4%. Alpha Cognition is the larger company by market cap ($196.9 million vs $165.3 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACOG | IPHA |
|---|---|---|
| Share price | $9.04 | $1.48 |
| Market cap | $196.87M | $165.32M |
| 1-day change | 0.00% | -2.63% |
| YTD return | +39.08% | -15.43% |
| 1-year return | +17.10% | -26.37% |
| 5-year return | — | -74.79% |
| EPS (TTM) | $-1.33 | $-0.59 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.14 | $2.71 |
| 52-week low | $4.50 | $1.17 |
| Distance from 52-week high | -10.85% | -45.39% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +99.12% | +350.68% |
| Average volume | 125.72K | 156.96K |
| Shares outstanding | 21.78M | 111.70M |
| Employees | 71 | 120 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ACOG has outperformed IPHA by 43.5 percentage points over the past year.
About Alpha Cognition
ACOG stock →Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease.
Healthcare · Biotechnology · 71 employees
About Innate Pharma S.A.
IPHA stock →Innate Pharma S.A. operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.
Healthcare · Biotechnology · 120 employees
ACOG vs IPHA FAQ
Which is bigger, Alpha Cognition or Innate Pharma S.A.?
Alpha Cognition (ACOG) is larger, with a market capitalization of $196.87M compared with $165.32M for Innate Pharma S.A. (IPHA).
Which stock has performed better over the past year, ACOG or IPHA?
ACOG returned +17.10% over the past 12 months, compared with -26.37% for IPHA (price return, excluding dividends). Past performance does not predict future results.
Are Alpha Cognition and Innate Pharma S.A. in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.